VVP
IHE icon

Venture Visionary Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Venture Visionary Partners’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-825
Closed -$52.7K – 974
2022
Q2 		$52.7K Buy
+825
New +$52.4K ﹤0.01% 791

Other funds holding IHE

Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Venture Visionary Partners's IHE Position: Q3 2022 in Review

Venture Visionary Partners sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2022, closing a stake of 825 shares — an estimated $52.7K sold.

Venture Visionary Partners first reported a position in IHE in Q2 2022 and held it in 1 quarter. The position peaked at $52.7K in Q2 2022. 113 funds tracked by Wall St. Rank hold IHE as of Q3 2022.

  • Venture Visionary Partners reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 825 iShares US Pharmaceuticals ETF shares in Q3 2022, an estimated $52.7K.
  • Venture Visionary Partners first reported a position in iShares US Pharmaceuticals ETF in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's iShares US Pharmaceuticals ETF position peaked at $52.7K in Q2 2022.
  • 113 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.